The H1N1 vaccine (injectable) will be distributed to established patients of the practice on a first-come, first-served basis. Priority will be limited to the following five target groups until vaccine availability increases.
  1. Pregnant women
  2. Persons who live with or provide care for infants less than 6 months of age (parents, siblings and daycare providers, etc.)
  3. Healthcare and emergency medical services personnel
  4. Persons 6 months through 24 years of age
  5. Persons 25-64 years of age who have medical conditions* that put them at higher risk for influenza-related complications

*Chronic medical conditions that confer a higher risk for influenza-related compliations include chronic pulmonary (including asthma), cardiovascular (except hypertension), renal, hepatic, congnitive, neurologic/neuromuscular, hematologic, or metabolid disorders (including diabetes mellitus) or immunosuppression (including immunosuppression caused by medications or by human immunodeficiency virus).

H1N1 Influenza Vaccine Consent Form